Jimmy Gollihar
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 8
- COVID-19 Clinical Research Studies 4
- Molecular Biology top 10%
- CRISPR and Genetic Engineering 10
- RNA and protein synthesis mechanisms 6
- Advanced biosensing and bioanalysis techniques 3
- Obstetrics and Gynecology top 10%
- Biotechnology top 10%
- Neurology top 10%
-
- Bacterial Genetics and Biotechnology 5
-
- Monoclonal and Polyclonal Antibodies Research 4
-
- T-cell and B-cell Immunology 3
- Co-authors
- Andrew D. EllingtonArti PothukuchyJared W. EllefsonBingling LiYan DuRaghav ShroffJames M. MusserPaul Christensen
- Journals
- Science (2 papers)Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (1 paper)
- Partner nations
- United StatesCanadaChina
In The Last Decade
Jimmy Gollihar
33 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Infectious Diseases 451
- Molecular Biology 746
- Obstetrics and Gynecology 75
- Biotechnology 55
- Neurology 95
Countries citing papers authored by Jimmy Gollihar
This map shows the geographic impact of Jimmy Gollihar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jimmy Gollihar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jimmy Gollihar more than expected).
Fields of papers citing papers by Jimmy Gollihar
This network shows the impact of papers produced by Jimmy Gollihar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jimmy Gollihar. The network helps show where Jimmy Gollihar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jimmy Gollihar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 2 | |
| 4 | 2022 | 17 | |
| 5 | Signals of Significantly Increased Vaccine Breakthrough, Decreased Hospitalization Rates, and Less Severe Disease in Patients with Coronavirus Disease 2019 Caused by the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Houston, Texasbreakdown → | 2022 | 127 |
| 6 | 2022 | 19 | |
| 7 | 2021 | 7 | |
| 8 | 2021 | 36 | |
| 9 | 2021 | 10 | |
| 10 | 2020 | 22 | |
| 11 | 2020 | 97 | |
| 12 | 2020 | 92 | |
| 13 | 2020 | 1 | |
| 14 | 2018 | 15 | |
| 15 | 2018 | 34 | |
| 16 | 2018 | 30 | |
| 17 | 2017 | 34 | |
| 18 | 2017 | 17 | |
| 19 | 2016 | 50 | |
| 20 | 2016 | 10 |
About Jimmy Gollihar
Jimmy Gollihar is a scholar working on Infectious Diseases, Molecular Biology and Genetics, having authored 36 papers that have together received 1.3k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (10 papers), SARS-CoV-2 and COVID-19 Research (8 papers), RNA and protein synthesis mechanisms (6 papers), Bacterial Genetics and Biotechnology (5 papers), COVID-19 Clinical Research Studies (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Advanced biosensing and bioanalysis techniques (3 papers) and T-cell and B-cell Immunology (3 papers). The work is most often cited by research in Infectious Diseases (451 citations), Molecular Biology (746 citations) and Obstetrics and Gynecology (75 citations). Jimmy Gollihar has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Andrew D. Ellington, Arti Pothukuchy, Jared W. Ellefson, Bingling Li, Yan Du, Raghav Shroff, James M. Musser, Paul Christensen, Barrett R. Morrow and Ross Thyer. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.